Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118456) titled 'A Study on the Efficacy and Safety of Two Microstructure Design Lenses in Slowing Myopia Progression: A Parallel, Randomized Controlled Trial' on Feb. 5.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Eye Hospital of Wenzhou Medical University
Condition:
Myopia
Intervention:
Group A:H.E.A.L Technology Lens
Group B:H.E.A.L MAX Technology Lens
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-15
Target Sample Size: Group A:60;Group B:60;Control Group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.htm...